Retrospective analysis of 32 alpha-fetoprotein-producing gastric cancer

TIAN Lan-tian,YAO Ke,WU Ao,LI Long,ZHANG Zhi-cheng,PEI Tie-min,LIU Lian-xin

DOI: https://doi.org/10.3969/j.issn.1009-9905.2011.06.006

2011-01-01

Abstract:Objective:To investigate the clinicopathologic characteristics,treatments and prognostic factors of AFPGC.Methods: 468 gastric cancer medical files preserved at the medical record library were retrospectively reviewed.There were 67 patients with elevated serum level of AFP among these patients who were made a definite diagnosis of gastric cancer and subsequently received surgery and systemic combined therapy at the First Affiliated Hospital of Haerbin Medical University(FAHHMU) between January 2001 and January 2007.Having excluded some diseases as hepatocirrhosis,liver tumor,germ cell tumor which can increase the level of serum AFP,32(6.8%) patients were made the definite diagnosis of AFPGC.The diagnostic,therapeutic and follow up files were reviewed.Finally,these follow-up results and correlative laboratory data were taken into statistical treatment.Results: There were 32 AFPGC which accounting for 6.8% of the gastric cancer of the corresponding time period.Compared with the negative group,there was a significantly higher incidence of lymph node and liver metastasis in AFPGC group(P=0.025 and 0.011,respectively).Clinically,AFPGC was not sensitive to the commonly used chemotherapy regimens and it couldn't suppress the progression of AFPGC.20 of the AFPGC patients died of tumor liver metastatis and the mean postoperative servial time of the cohort was 35.7 months.Conclusion: AFPGC has more aggressive behavior than that of AFP-negative gastric cancer.Patients with AFPGC are proned to proceed liver metastatis and the prognosis is very poor.Radical correction is the preferred way to deal with AFPGC and the postoperative adjuvant chemotherapy is necessary.